NRXS vs SYK · rev $3.6M vs P/E 35, rev $6.59B
Neuraxis, Inc. (NRXS) versus Stryker Corporation (SYK) — a side-by-side from cached financials, not a winner call.
Neuraxis, Inc. (NRXS) is a biotechnology company listed on AMEX.
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
Latest reported NRXS revenue for 2025-12-31 was $3.6M. Net income was -$7.8M. Revenue was up 32.9% from 2024-12-31 to 2025-12-31. NRXS currently screens at market cap $83.1M.
Latest reported SYK revenue for 2026-06-30 was $6.59B. Net income was $1.28B. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
NRXS currently screens at market cap $83.1M. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
Not investment advice. Open the NRXS and SYK stock pages for the full models.
Not investment advice.